IJDVL Home  

[View FULLTEXT] [Download PDF]  
Year : 2012  |  Volume : 78  |  Issue : 1  |  Page : 42-48

Ultraviolet-based therapy for vitiligo: What«SQ»s new?

Iltefat H Hamzavi, Henry W Lim, Zain U Syed 
 Department of Dermatology, Multicultural Dermatology Center, Henry Ford Hospital, Detroit, Michigan, USA

Correspondence Address:
Iltefat H Hamzavi
Department of Dermatology, Henry Ford Hospital, Detroit, MI 48202

Vitiligo is an ancient disease in which depigmented and hypopigmented macules appear on the skin. It is a disfiguring condition that may lead to severe psychological trauma. Among the many treatment modalities available for use in vitiligo, those using light therapy, and in particular ultraviolet (UV) light, are some of the most effective treatments. UV-based therapy includes phototherapy (narrowband UVB), photochemotherapy (psoralens with UVA), and targeted phototherapy (excimer laser and excimer lamp). It is important for any practitioner of UV-based therapy to understand the efficacy of each treatment type, as well as their respective adverse effects. In order to take full advantage of UV-based therapy, location, dosing, and photoadaptation must also be taken into account. This review discusses the various UV-based therapeutic options, adjuvant therapies, optimal dosing guidelines, appropriate patient selection, future treatment options, and recommendations based upon the current evidence and the authors«SQ» experience with vitiligo.

How to cite this article:
Hamzavi IH, Lim HW, Syed ZU. Ultraviolet-based therapy for vitiligo: What's new?.Indian J Dermatol Venereol Leprol 2012;78:42-48

How to cite this URL:
Hamzavi IH, Lim HW, Syed ZU. Ultraviolet-based therapy for vitiligo: What's new?. Indian J Dermatol Venereol Leprol [serial online] 2012 [cited 2020 Jul 5 ];78:42-48
Available from: http://www.ijdvl.com/article.asp?issn=0378-6323;year=2012;volume=78;issue=1;spage=42;epage=48;aulast=Hamzavi;type=0


Sunday, July 5, 2020
 Site Map | Home | Contact Us | Feedback | Copyright and disclaimer